Kiniksa Pharmaceuticals International Plc (KNSA)

$38.93 +0.16 (0.41%)
Market Cap 2.87B
Revenue (ttm) 423.24M
Net Income (ttm) -43.19M
EPS (ttm) N/A
PE Ratio 972.50
Forward PE 37.52
Profit Margin -10.20%
Debt to Equity Ratio 0.00
Volume 789,400
Avg Vol 429,896
Day's Range N/A - N/A
Shares Out 74.11M
Stochastic %K 71%
Beta 0.16
Analysts Strong Sell
Price Target $48.50

Company Profile

Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatment of recurrent pericarditis, which is an inflammatory cardiovascular disease; Vixarelimab, a monoclonal antibody, that is in Phase 2b clinical trial for the treatment of prurigo nodularis, a chron...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 781 431 9100
Address:
23 Old Bond Street, Floor 3, London, United Kingdom
ObeCalp
ObeCalp Oct. 25 at 12:15 AM
$RLAY Adding $KNSA to the "fishy" bucket.
0 · Reply
Night_Owl_Biotech
Night_Owl_Biotech Oct. 21 at 7:40 PM
$FOLD continues to trade at lower multiples of projected sales versus 3 peers with like dollar forecasts & gross margin profiles. FOLD is currently defending its patent rights against a generic pharma hoping to sell a biosimilar. We suspect this could be the reason why FOLD does not trade at like multiples versus its peers $MIRM $TARS $KNSA Again by peers we mean those commercial-stage bios with similar revenue projections & patent lives. This is not investment advice. $IBB
2 · Reply
JarvisFlow
JarvisFlow Oct. 17 at 3:23 PM
Citigroup has adjusted their stance on Kiniksa Pharmaceuticals ( $KNSA ), setting the rating to Buy with a target price of 45 → 50.
0 · Reply
ap20
ap20 Oct. 15 at 7:45 PM
$KNSA anybody sniffing a 40?
1 · Reply
limitsean
limitsean Oct. 5 at 9:19 AM
$KNSA Biotech with clinical catalyst. High short interest. Volatility expansion expected. Pure binary event risk.
0 · Reply
BDE_Worldwide
BDE_Worldwide Sep. 29 at 9:47 PM
$KNSA very quiet board for hitting all time highs.. 🤔 Takeout candidate in 2026.
1 · Reply
Rascal7777777
Rascal7777777 Sep. 29 at 7:23 PM
$VRNA $KNSA ????
1 · Reply
ap20
ap20 Sep. 29 at 6:20 PM
$KNSA Cowen upgrade to 60. 52 week and I think all time high today on decent volume.
0 · Reply
xbibackto65s
xbibackto65s Sep. 25 at 8:26 PM
$KNSA fn dick tease all day w flat and slight green!
0 · Reply
xbibackto65s
xbibackto65s Sep. 19 at 3:19 PM
$KNSA addind more
0 · Reply
Latest News on KNSA
Kiniksa Pharmaceuticals to Report Third Quarter 2025 Financial Results on October 28, 2025

Oct 23, 2025, 4:01 PM EDT - 1 day ago

Kiniksa Pharmaceuticals to Report Third Quarter 2025 Financial Results on October 28, 2025

Kiniksa Pharmaceuticals Announces U.S. Orphan Drug Designation for KPL-387 for the Treatment of Pericarditis

Oct 17, 2025, 8:00 AM EDT - 8 days ago

Kiniksa Pharmaceuticals Announces U.S. Orphan Drug Designation for KPL-387 for the Treatment of Pericarditis

Kiniksa Pharmaceuticals International, Plc (KNSA) Presents At Citi's Biopharma Back To School Conference Transcript

Sep 3, 2025, 1:57 PM EDT - 7 weeks ago

Kiniksa Pharmaceuticals International, Plc (KNSA) Presents At Citi's Biopharma Back To School Conference Transcript

Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences

Aug 28, 2025, 4:01 PM EDT - 2 months ago

Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences

Kiniksa Pharmaceuticals International, plc (KNSA) Q2 2025 Earnings Call Transcript

Jul 29, 2025, 10:34 AM EDT - 3 months ago

Kiniksa Pharmaceuticals International, plc (KNSA) Q2 2025 Earnings Call Transcript

Kiniksa Pharmaceuticals Reports Second Quarter 2025 Financial Results and Recent Portfolio Execution

Jul 29, 2025, 7:30 AM EDT - 3 months ago

Kiniksa Pharmaceuticals Reports Second Quarter 2025 Financial Results and Recent Portfolio Execution

Kiniksa Pharmaceuticals to Report Second Quarter 2025 Financial Results on July 29, 2025

Jul 24, 2025, 4:01 PM EDT - 3 months ago

Kiniksa Pharmaceuticals to Report Second Quarter 2025 Financial Results on July 29, 2025

Kiniksa Pharmaceuticals: Arcalyst Performs, KPL-387 Advancing Fast

Jun 16, 2025, 8:15 AM EDT - 4 months ago

Kiniksa Pharmaceuticals: Arcalyst Performs, KPL-387 Advancing Fast

Kiniksa Pharmaceuticals Announces Trial Design of Planned Phase 2/3 Clinical Trial of KPL-387 in Recurrent Pericarditis

Jun 5, 2025, 7:00 AM EDT - 5 months ago

Kiniksa Pharmaceuticals Announces Trial Design of Planned Phase 2/3 Clinical Trial of KPL-387 in Recurrent Pericarditis

Kiniksa Pharmaceuticals: Making Steady Progress

May 5, 2025, 4:51 PM EDT - 6 months ago

Kiniksa Pharmaceuticals: Making Steady Progress

Kiniksa Pharmaceuticals Announces GRAMMY® Award-Winning Country Star, Carly Pearce, Joins the Life DisRPted™ Campaign, Adding to Voices Advocating for Awareness of Recurrent Pericarditis

Apr 30, 2025, 8:30 AM EDT - 6 months ago

Kiniksa Pharmaceuticals Announces GRAMMY® Award-Winning Country Star, Carly Pearce, Joins the Life DisRPted™ Campaign, Adding to Voices Advocating for Awareness of Recurrent Pericarditis

Kiniksa Pharmaceuticals International, plc (KNSA) Q1 2025 Earnings Call Transcript

Apr 29, 2025, 3:07 PM EDT - 6 months ago

Kiniksa Pharmaceuticals International, plc (KNSA) Q1 2025 Earnings Call Transcript

Kiniksa Pharmaceuticals Reports First Quarter 2025 Financial Results and Recent Portfolio Execution

Apr 29, 2025, 7:30 AM EDT - 6 months ago

Kiniksa Pharmaceuticals Reports First Quarter 2025 Financial Results and Recent Portfolio Execution

Kiniksa Pharmaceuticals to Report First Quarter 2025 Financial Results on April 29, 2025

Apr 24, 2025, 4:01 PM EDT - 6 months ago

Kiniksa Pharmaceuticals to Report First Quarter 2025 Financial Results on April 29, 2025

Big Pipeline Updates From Kiniksa Pharmaceuticals

Feb 25, 2025, 4:14 PM EST - 8 months ago

Big Pipeline Updates From Kiniksa Pharmaceuticals

Kiniksa Pharmaceuticals International, plc (KNSA) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 10:53 AM EST - 8 months ago

Kiniksa Pharmaceuticals International, plc (KNSA) Q4 2024 Earnings Call Transcript

Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Portfolio Execution

Feb 25, 2025, 7:30 AM EST - 8 months ago

Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Portfolio Execution

Kiniksa Pharmaceuticals Announces Development of KPL-387 in Recurrent Pericarditis and Updates Corporate Strategy

Feb 25, 2025, 7:29 AM EST - 8 months ago

Kiniksa Pharmaceuticals Announces Development of KPL-387 in Recurrent Pericarditis and Updates Corporate Strategy

Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025

Feb 20, 2025, 4:01 PM EST - 8 months ago

Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025

Kiniksa Pharmaceuticals Reports Preliminary 2024 Net Product Revenue and Provides 2025 Net Product Revenue Guidance

Jan 13, 2025, 7:30 AM EST - 10 months ago

Kiniksa Pharmaceuticals Reports Preliminary 2024 Net Product Revenue and Provides 2025 Net Product Revenue Guidance

Kiniksa Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference

Jan 6, 2025, 4:01 PM EST - 10 months ago

Kiniksa Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference

Kiniksa Pharmaceuticals to Present at 7th Annual Evercore ISI HealthCONx Conference

Nov 26, 2024, 4:01 PM EST - 11 months ago

Kiniksa Pharmaceuticals to Present at 7th Annual Evercore ISI HealthCONx Conference

Kiniksa Pharmaceuticals to Present at Jefferies London Healthcare Conference

Nov 12, 2024, 4:01 PM EST - 1 year ago

Kiniksa Pharmaceuticals to Present at Jefferies London Healthcare Conference

Kiniksa Pharmaceuticals International, plc (KNSA) Q3 2024 Earnings Call Transcript

Oct 29, 2024, 11:45 AM EDT - 1 year ago

Kiniksa Pharmaceuticals International, plc (KNSA) Q3 2024 Earnings Call Transcript

Kiniksa Pharmaceuticals Reports Third Quarter 2024 Financial Results and Recent Portfolio Execution

Oct 29, 2024, 7:30 AM EDT - 1 year ago

Kiniksa Pharmaceuticals Reports Third Quarter 2024 Financial Results and Recent Portfolio Execution

Kiniksa Pharmaceuticals to Report Third Quarter 2024 Financial Results on October 29, 2024

Oct 22, 2024, 4:01 PM EDT - 1 year ago

Kiniksa Pharmaceuticals to Report Third Quarter 2024 Financial Results on October 29, 2024

Kiniksa Pharmaceuticals to Present at 2024 Wells Fargo Healthcare Conference

Aug 28, 2024, 4:01 PM EDT - 1 year ago

Kiniksa Pharmaceuticals to Present at 2024 Wells Fargo Healthcare Conference

Kiniksa Pharmaceuticals: Improved Outlook For Arcalyst After Q2 Beat

Jul 24, 2024, 5:38 AM EDT - 1 year ago

Kiniksa Pharmaceuticals: Improved Outlook For Arcalyst After Q2 Beat

Kiniksa Pharmaceuticals International, plc (KNSA) Q2 2024 Earnings Call Transcript

Jul 23, 2024, 1:30 PM EDT - 1 year ago

Kiniksa Pharmaceuticals International, plc (KNSA) Q2 2024 Earnings Call Transcript

Kiniksa Pharmaceuticals Reports Second Quarter 2024 Financial Results and Recent Portfolio Execution

Jul 23, 2024, 7:30 AM EDT - 1 year ago

Kiniksa Pharmaceuticals Reports Second Quarter 2024 Financial Results and Recent Portfolio Execution

Kiniksa Pharmaceuticals to Report Second Quarter 2024 Financial Results on July 23, 2024

Jul 16, 2024, 4:01 PM EDT - 1 year ago

Kiniksa Pharmaceuticals to Report Second Quarter 2024 Financial Results on July 23, 2024

Kiniksa Pharmaceuticals Commences Enrollment in Abiprubart Phase 2b Clinical Trial in Sjögren's Disease

Jul 9, 2024, 8:00 AM EDT - 1 year ago

Kiniksa Pharmaceuticals Commences Enrollment in Abiprubart Phase 2b Clinical Trial in Sjögren's Disease

Kiniksa Pharmaceuticals Sponsors American Heart Association's Addressing Recurrent Pericarditis Initiative

Jun 17, 2024, 8:30 AM EDT - 1 year ago

Kiniksa Pharmaceuticals Sponsors American Heart Association's Addressing Recurrent Pericarditis Initiative

Kiniksa Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference

Jun 4, 2024, 4:01 PM EDT - 1 year ago

Kiniksa Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference

Kiniksa Pharmaceuticals to Present at Bank of America Securities 2024 Health Care Conference

May 7, 2024, 4:01 PM EDT - 1 year ago

Kiniksa Pharmaceuticals to Present at Bank of America Securities 2024 Health Care Conference

Kiniksa Pharmaceuticals: Arcalyst Performs While Abiprubart Plans Take Shape

Apr 24, 2024, 1:34 PM EDT - 1 year ago

Kiniksa Pharmaceuticals: Arcalyst Performs While Abiprubart Plans Take Shape

Kiniksa Pharmaceuticals Ltd. (KNSA) Q1 2024 Earnings Call Transcript

Apr 23, 2024, 1:59 PM EDT - 1 year ago

Kiniksa Pharmaceuticals Ltd. (KNSA) Q1 2024 Earnings Call Transcript

Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution

Apr 23, 2024, 7:30 AM EDT - 1 year ago

Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution

Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024

Apr 16, 2024, 4:01 PM EDT - 1 year ago

Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024

Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart

Apr 2, 2024, 7:30 AM EDT - 1 year ago

Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart

Kiniksa Pharmaceuticals Ltd. (KNSA) Q4 2023 Earnings Call Transcript

Feb 28, 2024, 11:58 AM EST - 1 year ago

Kiniksa Pharmaceuticals Ltd. (KNSA) Q4 2023 Earnings Call Transcript

Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Portfolio Execution

Feb 28, 2024, 7:30 AM EST - 1 year ago

Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Portfolio Execution

Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024

Feb 21, 2024, 4:01 PM EST - 1 year ago

Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024

Kiniksa Pharmaceuticals: Early 2024 Corporate Update A Mixed Bag

Jan 5, 2024, 4:29 PM EST - 1 year ago

Kiniksa Pharmaceuticals: Early 2024 Corporate Update A Mixed Bag

Kiniksa Pharmaceuticals Provides Corporate Update

Jan 4, 2024, 7:30 AM EST - 1 year ago

Kiniksa Pharmaceuticals Provides Corporate Update

Kiniksa Pharmaceuticals to Present at 42nd Annual J.P. Morgan Healthcare Conference

Jan 2, 2024, 4:01 PM EST - 1 year ago

Kiniksa Pharmaceuticals to Present at 42nd Annual J.P. Morgan Healthcare Conference

Kiniksa Pharmaceuticals: Arcalyst Performs While KPL-404 Advances Toward Early 2024 Readout

Nov 3, 2023, 11:07 AM EDT - 2 years ago

Kiniksa Pharmaceuticals: Arcalyst Performs While KPL-404 Advances Toward Early 2024 Readout

Kiniksa Pharmaceuticals Ltd (KNSA) Q3 2023 Earnings Call Transcript

Oct 31, 2023, 2:35 PM EDT - 2 years ago

Kiniksa Pharmaceuticals Ltd (KNSA) Q3 2023 Earnings Call Transcript

Kiniksa Pharmaceuticals Reports Third Quarter 2023 Financial Results and Recent Portfolio Execution

Oct 31, 2023, 7:30 AM EDT - 2 years ago

Kiniksa Pharmaceuticals Reports Third Quarter 2023 Financial Results and Recent Portfolio Execution

Kiniksa Pharmaceuticals to Report Third Quarter 2023 Financial Results on October 31, 2023

Oct 24, 2023, 4:01 PM EDT - 2 years ago

Kiniksa Pharmaceuticals to Report Third Quarter 2023 Financial Results on October 31, 2023

ObeCalp
ObeCalp Oct. 25 at 12:15 AM
$RLAY Adding $KNSA to the "fishy" bucket.
0 · Reply
Night_Owl_Biotech
Night_Owl_Biotech Oct. 21 at 7:40 PM
$FOLD continues to trade at lower multiples of projected sales versus 3 peers with like dollar forecasts & gross margin profiles. FOLD is currently defending its patent rights against a generic pharma hoping to sell a biosimilar. We suspect this could be the reason why FOLD does not trade at like multiples versus its peers $MIRM $TARS $KNSA Again by peers we mean those commercial-stage bios with similar revenue projections & patent lives. This is not investment advice. $IBB
2 · Reply
JarvisFlow
JarvisFlow Oct. 17 at 3:23 PM
Citigroup has adjusted their stance on Kiniksa Pharmaceuticals ( $KNSA ), setting the rating to Buy with a target price of 45 → 50.
0 · Reply
ap20
ap20 Oct. 15 at 7:45 PM
$KNSA anybody sniffing a 40?
1 · Reply
limitsean
limitsean Oct. 5 at 9:19 AM
$KNSA Biotech with clinical catalyst. High short interest. Volatility expansion expected. Pure binary event risk.
0 · Reply
BDE_Worldwide
BDE_Worldwide Sep. 29 at 9:47 PM
$KNSA very quiet board for hitting all time highs.. 🤔 Takeout candidate in 2026.
1 · Reply
Rascal7777777
Rascal7777777 Sep. 29 at 7:23 PM
$VRNA $KNSA ????
1 · Reply
ap20
ap20 Sep. 29 at 6:20 PM
$KNSA Cowen upgrade to 60. 52 week and I think all time high today on decent volume.
0 · Reply
xbibackto65s
xbibackto65s Sep. 25 at 8:26 PM
$KNSA fn dick tease all day w flat and slight green!
0 · Reply
xbibackto65s
xbibackto65s Sep. 19 at 3:19 PM
$KNSA addind more
0 · Reply
xbibackto65s
xbibackto65s Sep. 18 at 7:09 PM
$KNSA wake up!!! look at xbi!!
0 · Reply
xbibackto65s
xbibackto65s Sep. 15 at 3:21 PM
$KNSA Adding
0 · Reply
ap20
ap20 Sep. 8 at 4:54 PM
$KNSA Nice little run continues.
0 · Reply
Massimino
Massimino Sep. 8 at 12:49 PM
$KNSA my best performing stock this year!!
0 · Reply
Doozio
Doozio Sep. 5 at 12:52 PM
$KNSA out of the tightness during 🐒🍌🧠⏰♾️
0 · Reply
Happy_Feet19
Happy_Feet19 Sep. 3 at 10:02 PM
$KNSA Good fireside chat today. They have a very detailed updated corp. presentation on their website. I have ask this question in the past years that I have owned this stock but can anyone tell me why this great company with awesome revenue with no competition is not for sale. I would think some big parma like Roche would buy them out. Thoughts?
1 · Reply
ap20
ap20 Sep. 3 at 7:12 PM
$KNSA nice move today.
0 · Reply
ap20
ap20 Aug. 31 at 1:41 AM
$KNSA 26 days without a post.. I thought I’d post something.. It hasn’t gone down!
0 · Reply
topstockalerts
topstockalerts Aug. 4 at 10:56 AM
Pre Market Top Gainers PT2 $UNIT $SLE $BTAI $KNSA $BLDE
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Aug. 3 at 2:59 AM
$KNSA Trading at $31.98, hitting the highest point today. With an average volume of 551,318, today's volume is lower than yesterday's.
0 · Reply
BDE_Worldwide
BDE_Worldwide Aug. 1 at 8:35 PM
$KNSA really digging this move today! Finally time to put $30 in the rearview??
0 · Reply
OptionRunners
OptionRunners Aug. 1 at 7:16 PM
$KNSA taking out the earnings highs from a few days ago. Really strong today in this ugly tape. Calls up to about $3.70 now Guy in the comments was arguing with me about how they were selling them lol. Careful who you follow.
0 · Reply